AIG
AQST icon

American International Group’s Aquestive Therapeutics AQST Stock Holding History

American International Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,581
Closed -$60 – 3111
2021
Q1 		$60 Buy
11,581
+31
+0.3% +$165 ﹤0.01% 2940
2020
Q4 		$62 Sell
11,550
-332
-3% -$1.99K ﹤0.01% 2884
2020
Q3 		$58K Sell
11,882
-271
-2% -$1.77K ﹤0.01% 2823
2020
Q2 		$59K Buy
+12,153
New +$56K ﹤0.01% 2816
2019
Q2 		– Sell
-7,211
Closed -$50K – 3104
2019
Q1 		$50K Buy
7,211
+3,772
+110% +$26.4K ﹤0.01% 2871
2018
Q4 		$22K Sell
3,439
-25
-0.7% -$316 ﹤0.01% 3014
2018
Q3 		$61K Buy
+3,464
New +$57.1K ﹤0.01% 3018

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LI
Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

American International Group's AQST Position: Q2 2021 in Review

American International Group sold out of Aquestive Therapeutics (AQST) in Q2 2021, closing a stake of 11,581 shares — an estimated $60 sold.

American International Group first reported a position in AQST in Q3 2018 and held it in 7 quarters. The position peaked at $61K in Q3 2018. 60 funds tracked by Wall St. Rank hold AQST as of Q2 2021.

  • American International Group reported no remaining Aquestive Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 11,581 Aquestive Therapeutics shares in Q2 2021, an estimated $60.
  • American International Group first reported a position in Aquestive Therapeutics in Q3 2018 and held it in 7 quarters.
  • American International Group's Aquestive Therapeutics position peaked at $61K in Q3 2018.
  • 60 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.